TATIANE DE COUTO: Open Payments
NPI 1619584778 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 55 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $844 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $150 |
| Actelion Pharmaceuticals US, Inc. | 5 | $102 |
| United Therapeutics Corporation | 3 | $96 |
| SCPHARMACEUTICALS INC. | 4 | $88 |
| Alnylam Pharmaceuticals Inc. | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $78 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| Novo Nordisk Inc | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Lilly USA, LLC | 2 | $38 |
Products named: Kerendia, Tyvaso, FUROSCIX, AMVUTTRA, JARDIANCE, Ozempic, WINREVAIR, OPSUMIT.
Industry payments across TN — which companies pay providers there.
